NNMT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NNMT monoclonal antibodies for investigating Nicotinamide N-methyltransferase (NNMT) in various biological processes. NNMT monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nicotinamide N-methyltransferase functions as a key enzyme in nicotinamide metabolism and maintains cellular energy homeostasis and methylation processes. NNMT dysregulation has been linked to various diseases, including cancer and metabolic disorders, highlighting its potential as a therapeutic target. Researchers can utilize NNMT monoclonal antibodies to examine protein expression patterns across different tissue types and experimental conditions. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of NNMT localization and expression. Understanding NNMT's biological functions through detailed molecular studies can reveal new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing NNMT research and uncovering new therapeutic possibilities.